Arkolith/Insider Trading/GLYC/Form 4

Rock Edwin

Chief Medical OfficerGLYCOMIMETICS INC (GLYC) · full profile →Form 4 · filed Nov 16, 2022
Net Buying
Open-Market Buys
$309K
Open-Market Sells
$0
Net Open-Market Flow
$309K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2022Buy(P)100K$1.66$166K200K
Nov 14, 2022Buy(P)100K$1.43$143K100K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-057314) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML